Skip to main content
OpenTrials
Completed

NCT Number: NCT02093884

A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department

The objective of this study is to develop and test an emergency department (ED)-based intervention which uses text messages to facilitate contraception initiation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–19 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Morgan Stanley Children's Hospital Emergency Department

Manhattan, New York, 10032, United States

About this study

Our hypothesis is that adolescent females at high pregnancy risk who receive text message reminders and motivational messages that promote contraception and referral to the Family Planning Clinic are more likely to start effective contraception than those who receive standard paper-based referral to the Family Planning Clinic alone.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 14-19 years
  • Sexually active with males in the past three months
  • Presenting to the ED for a reproductive health complaint.

Exclusion criteria

  • Presently pregnant
  • Too ill for participation per the attending physician
  • Cognitively impaired
  • In foster care or a ward of the state
  • Does not speak English or Spanish
  • Does not own a cellular or mobile phone with text messaging capabilities
  • Used contraception at last intercourse and/or is currently using any "highly effective" or "effective" form of contraception (as defined by the World Health Organization)
  • Does not live in Manhattan or the Bronx

Treatment and study plan

Text Messaging Intervention

Other

Standard Referral

Other

Primary outcomes

  1. Initiation of highly effective contraception, as defined by the World Health Organization.

    Time frame: 3 months after initial enrollment

    We will be assessing contraception initiation rates based on electronic medical record review and telephone call follow up.

Secondary outcomes

  1. Patient visits to Family Planning Clinic

    Time frame: 3 months after initial enrollment

    We assess Family Planning Clinic visits using our electronic medical records.

  2. Follow up for contraceptive counseling to a doctor or nurse

    Time frame: 3 months after initial enrollment

    We will be asking patients during our phone call follow if they have had contraceptive counseling with any healthcare professional. We will also be looking through electronic medical records for documentation of contraceptive counseling such as by ICD-9 coding or a physician's/nurse's note.

  3. Change in pregnancy intentions

    Time frame: 3 months after initial enrollment

    We will compare pregnancy intentions elicited from the answers provided in the baseline questionnaire to those reported on the telephone follow up for both study arms.

Other outcomes

  1. Text messaging intervention safety

    Time frame: 3 months after initial enrollment

    Safety will be assessed during the telephone follow up.

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • Society of Family Planning

Registry information

Official study title

Texting 2 Initiate: A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department (T2I)

Acronym: T2I

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Mar 21, 2014
Registry last updated
Jan 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.